spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Medarex 

 HSMN NewsFeed - 5 Aug 2019
Aprea Therapeutics Appoints Scott Coiante as Chief Financial Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Sep 2016
aTyr Pharma Appoints Industry Veteran in Novel Biology Biologics, David J. King, PhD, as Senior Vice President, Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2016
Tunitas Therapeutics Expands Management Team with Appointment of David J. King as Senior Vice President, Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2016
Lion Biotechnologies Names Steven A. Fischkoff Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Aug 2015
CytomX Announces Management Team Promotions
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Sep 2014
Dimension Therapeutics Names Annalisa Jenkins as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2014
Celldex Therapeutics Announces Senior Leadership Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2014
Novira Names Christian S. Schade Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Dec 2013
Crescendo Biologics Raises £17.5M ($28M) in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 27 Mar 2012
Synta Announces Appointment of George Farmer, Ph.D., as Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Aug 2011
Christian S. Schade to Join Omthera Pharmaceuticals as Executive Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Jul 2011
Celldex Expands Senior Management Team with Appointment of Dr. Ronald A. Pepin, Senior Vice President and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jun 2011
Tetragenetics Announces New CEO and Expands Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2010
Zymeworks Closes $3.2 Million Round of Financing and Announces the Addition of Dr. Donald Drakeman to Its Board of Directors
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 9 Dec 2009
Oxford BioTherapeutics Appoints Michael Moore as Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Sep 2009
GENova names Dr. John Savin as Vice President
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Aug 2009
Kolltan Pharmaceuticals Expands Board of Directors and Senior Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Jul 2009
Bristol-Myers Squibb Begins Tender Offer to Acquire Medarex, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Apr 2009
Merck & Co., Inc., Medarex, Inc. and Massachusetts Biologic Laboratories Sign Exclusive Licensing Agreement for Investigational Monoclonal Antibody Combination for Clostridium Difficile Infection
Biopharmaceuticals Licensing
 HSMN NewsFeed - 29 Sep 2008
AVANT Immunotherapeutics Announces Name Change to Celldex Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Apr 2008
Medarex Announces Ipilimumab Program Continues to Move Forward
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Mar 2008
Avalon Pharmaceuticals Appoints Philip Frost, M.D., Ph.D., to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Oct 2007
AVANT Immunotherapeutics, Inc. and Celldex Therapeutics, Inc. Announce Merger Agreement
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Oct 2007
Medarex Announces the Appointment of Ursula B. Bartels as Senior Vice President, General Counsel and Secretary
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2007
Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
Biopharmaceuticals
 HSMN NewsFeed - 6 Aug 2007
Avalon Pharmaceuticals Appoints Bradley G. Lorimier Chairman of Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jul 2007
Medarex Announces Initiation by Licensing Partner of Phase III Clinical Trial for Muckle Wells Syndrome
Biopharmaceuticals
 HSMN NewsFeed - 5 Jun 2007
Vanda Pharmaceuticals Announces Board Changes
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 3 Jun 2007
Celldex Therapeutics Announces Updated EGFRvIII Vaccine Data in Glioblastoma Multiforme Presented at ASCO Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2007
Medarex Announces the Appointment of Mr. Howard H. Pien as President and Chief Executive Officer and Member of the Medarex Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 May 2007
Medarex and Organon Announce Biotherapeutics Development Agreement
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 May 2007
Avalon Pharmaceuticals, Inc. Names C. Eric Winzer New Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2007
Medarex Announces Enrollment Complete in Ipilimumab (MDX-010) Monotherapy Pivotal Registrational Trial for Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jan 2007
Avalon Pharmaceuticals Names Clinical Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Dec 2006
IDM Pharma Announces Acceptance for Review of the NDA for Junovan(TM) (Mifamurtide)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Dec 2006
GlaxoSmithKline and Genmab Enter Global Agreement For HuMax-CD20
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Dec 2006
Medarex Announces FDA Fast Track Designations for Ipilimumab for the Treatment of Metastatic Melanoma; Fast Track Designations for First-Line Use in Combination With Chemotherapy and Second-Line Use as Monotherapy
Biopharmaceuticals FDA Oncology
 HSMN NewsFeed - 7 Nov 2006
IDM Pharma Submits Filing for European Market Approval of Mepact(TM) (mifamurtide, Junovan(TM) in the US) in the Treatment of Osteosarcoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 26 Oct 2006
IDM Pharma Submits New Drug Application to the FDA for Junovan(TM) (mifamurtide) in the Treatment of Osteosarcoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 12 Oct 2006
Multispan Announces Licensing Agreement With Medarex
Biopharmaceuticals Licensing
 HSMN NewsFeed - 15 Sep 2006
Medarex Announces Election of Two New Board Members
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2006
Genmab Initiates HuMax-EGFr Pivotal Study In Refractory Head and Neck Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Aug 2006
IDM Pharma Appoints Sylvie Gregoire, Pharm. D., as Executive Chair of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Aug 2006
Ono and Medarex Announce Allowance of Investigational New Drug Application for MDX-1106 for the Treatment of Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Jul 2006
Steven Fischkoff, M.D. Joins Palatin Technologies as Vice President of Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 May 2006
Celldex appoints Thomas Davis, M.D as Chief Medical Officer and Tibor Keler, Ph.D as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2006
Biolex Therapeutics Announces Expansion of Medarex Collaboration
Biopharmaceuticals
 HSMN NewsFeed - 31 Mar 2006
Medarex Announces Initiation of Registrational Trial for Ipilimumab (MDX-010) as Monotherapy in Previously-Treated Metastatic Melanoma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Mar 2006
Diatos Announces Expansion of Medarex Cancer Product Licensing Agreement
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 14 Mar 2006
IDM and Medison Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in Israel
Biopharmaceuticals Distribution Licensing
 HSMN NewsFeed - 13 Mar 2006
Cell Genesys to Present Data From Two GVAX(R) Cancer Immunotherapy Clinical Trials at 2006 ASCO Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Mar 2006
PharmAthene and Medarex Receive Orphan Drug Designation for Valortim(TM) to Treat Anthrax Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Feb 2006
IDM Pharma Confirms Plans to Submit New Drug Application for Junovan(TM) for the Treatment of Osteosarcoma Following Pre-NDA Meeting with FDA
Biopharmaceuticals Oncology
 HSMN NewsFeed - 21 Feb 2006
IDM and GENESIS Pharma Sign an Exclusive Marketing Agreement for Junovan(TM) in South East Europe
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Jan 2006
PharmAthene and Medarex Receive FDA Fast Track Designation for Valortim(TM) for Treatment of Anthrax Infection
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Jan 2006
IDM Pharma Announces Departure of President
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2006
Genmab's HuMax-EGFr Awarded Fast Track Status From FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Jan 2006
Genmab Appoints Annarie Lyles as Head of Business Development
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 79

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 79 additional stories matching:
Medarex
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.